George Harrison Talbot, Director at Nabriva Therapeutics AG (NBRV), sold 400 shares at $1.01 ($21K) on 2017-05-15, disclosed to the SEC on 2017-05-17.
Open-market sale of $21k NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 50 | $51 | 0.2% |
| 2 | $101.50 | 50 | $5K | 24.5% |
| 3 | $1.02 | 50 | $51 | 0.2% |
| 4 | $1.03 | 100 | $103 | 0.5% |
| 5 | $102.27 | 50 | $5K | 24.7% |
| 6 | $103.00 | 100 |
| $10K |
| 49.8% |
| Total | $51.73 avg | 400 | $21K | 100% |
| Filing → |
| NBRV | SELL | 2017-06-01 | $21K | — | Filing → |
| NBRV | SELL | 2017-05-25 | $33K | — | Filing → |